A detailed history of Accent Capital Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Accent Capital Management, LLC holds 78 shares of ARGX stock, worth $46,328. This represents 0.02% of its overall portfolio holdings.

Number of Shares
78
Previous 68 14.71%
Holding current value
$46,328
Previous $29.2 Million 44.59%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$434.22 - $551.9 $4,342 - $5,519
10 Added 14.71%
78 $42.3 Million
Q2 2024

Aug 12, 2024

BUY
$356.01 - $451.55 $5,340 - $6,773
15 Added 28.3%
68 $29.2 Million
Q4 2023

Mar 19, 2024

BUY
$338.91 - $506.01 $17,962 - $26,818
53 New
53 $20.2 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.